Nutraplus India
No trades in 1Y
Key Insights
No strengths listed
Weaknesses
1- Company has low interest coverage ratio.
Technical Indicators
| Group | Signal | Bearish | Neutral | Bullish |
|---|---|---|---|---|
| Overall | Strong Bearish | 12 | 4 | 3 |
| Oscillators | Bullish | 2 | 4 | 3 |
| Moving Averages | Strong Bearish | 10 | 0 | 0 |
Oscillators
Bullish
Overall
Strong Bearish
Moving Averages
Strong Bearish
Key readings
- RSI (14)
- 31.16
- Neutral
- MACD (12,26,9)
- −0.36
- Bullish
- SMA (50)
- 3.37
- Bearish
- SMA (200)
- 5.06
- Bearish
As of , the latest day with price data, so these readings are not current.
Growth Rate
From the financial statements below. 10Y, 5Y, 3Y: compound annual growth to Mar 2026; 1Y: fiscal year to Mar 2026 against Mar 2025; TTM: four quarters to Jun 2026 against Jun 2025.
Revenue
| 10Y | −100.00% |
|---|---|
| 5Y | −100.00% |
| 3Y | Negative, narrowed by ₹0.06 Cr |
| 1Y | Zero base |
| TTM | Zero base |
Net profit
| 10Y | Turned to loss |
|---|---|
| 5Y | Loss narrowed by ₹24.18 Cr |
| 3Y | Loss widened by ₹0.18 Cr |
| 1Y | Loss widened by ₹0.29 Cr |
| TTM | Loss widened by ₹0.27 Cr |
Operating cash flow
| 10Y | Outflow narrowed by ₹9.22 Cr |
|---|---|
| 5Y | Outflow narrowed by ₹13.86 Cr |
| 3Y | Turned negative |
| 1Y | Turned negative |
| TTM | — |
TTM: Reported once a year, so there is no trailing-twelve-month figure.
Operating margin· change in pp
| 10Y | No sales |
|---|---|
| 5Y | Tiny sales |
| 3Y | No sales |
| 1Y | No sales |
| TTM | No sales |
Revenue by year
| Mar 2017 | ₹91.05 Cr |
|---|---|
| Mar 2018 | ₹109 Cr |
| Mar 2019 | ₹140 Cr |
| Mar 2020 | ₹107 Cr |
| Mar 2021 | ₹0.02 Cr |
| Mar 2022 | ₹0.10 Cr |
| Mar 2023 | −₹0.06 Cr |
| Mar 2024 | ₹0.00 Cr |
| Mar 2025 | ₹0.00 Cr |
| Mar 2026 | ₹0.00 Cr |
Net profit by year
| Mar 2017 | −₹6.26 Cr |
|---|---|
| Mar 2018 | ₹0.14 Cr |
| Mar 2019 | ₹2.19 Cr |
| Mar 2020 | −₹47.83 Cr |
| Mar 2021 | −₹24.52 Cr |
| Mar 2022 | −₹3.03 Cr |
| Mar 2023 | −₹0.16 Cr |
| Mar 2024 | −₹0.06 Cr |
| Mar 2025 | −₹0.05 Cr |
| Mar 2026 | −₹0.34 Cr |
Quarterly Results
₹ Cr| Particulars | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Expenses | 0.01 | 0.01 | 0.03 | 0.02 | 0 | 0 | 0.02 | 0.03 | 0.01 | 0.46 | 0.02 | 0.02 | 0.01 |
| Operating Profit | −0.01 | −0.01 | −0.03 | −0.02 | 0 | 0 | −0.02 | −0.03 | −0.01 | −0.46 | −0.02 | −0.02 | −0.01 |
| Other Income | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0.1 | 0 | 0.06 | 0.03 |
| Interest | 0 | 0 | 0 | 0 | 0 | 0 | 0 | −0.01 | 0 | 0 | 0 | 0 | 0 |
| Depreciation | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| PBT | −0.01 | −0.01 | −0.03 | −0.02 | 0 | 0 | −0.02 | −0.02 | −0.01 | −0.36 | −0.02 | 0.04 | 0.02 |
| Tax % | 0% | 0% | 0% | 0% | — | — | 0% | 0% | 0% | 0% | 0% | 0% | 0% |
| Net Profit | −0.01 | −0.01 | −0.03 | −0.02 | 0 | 0 | −0.02 | −0.02 | −0.01 | −0.36 | −0.02 | 0.04 | 0.02 |
| EPS (₹) | 0 | 0 | −0.01 | −0.01 | 0 | 0 | −0.01 | −0.01 | 0 | −0.11 | −0.01 | 0.01 | 0.01 |
Profit & Loss
₹ Cr| Particulars | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | TTM |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 65 | 77.51 | 91.05 | 109 | 140 | 107 | 0.02 | 0.1 | −0.06 | 0 | 0 | 0 | 0 |
| Expenses | 61.79 | 65.37 | 92.78 | 99.83 | 127 | 142 | 0.38 | 3.75 | 0.07 | 0.06 | 0.05 | 0.5 | 0.51 |
| Operating Profit | 3.21 | 12.14 | −1.73 | 9.31 | 12.66 | −35.77 | −0.36 | −3.65 | −0.13 | −0.06 | −0.05 | −0.5 | −0.51 |
| OPM % | 4.94% | 15.66% | −1.9% | 8.53% | 9.07% | −33.53% | Not meaningful for this period: the ratio divides by a base close to zero, so it is left blank rather than shown as a very large number. | Not meaningful for this period: the ratio divides by a base close to zero, so it is left blank rather than shown as a very large number. | — | — | — | — | — |
| Other Income | −2.94 | 1.48 | 0.99 | 0.12 | 1.58 | 0.08 | −23.36 | 0.62 | 0 | 0 | 0 | 0.16 | 0.19 |
| Interest | 4.52 | 4.86 | 5.01 | 4.67 | 6.85 | 7.43 | 0.8 | 0 | 0.03 | 0 | 0 | 0 | 0 |
| Depreciation | 1.4 | 1.72 | 2.21 | 3.88 | 4.03 | 4.7 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| PBT | −5.65 | 7.04 | −7.96 | 0.88 | 3.36 | −47.82 | −24.52 | −3.03 | −0.16 | −0.06 | −0.05 | −0.34 | −0.32 |
| Tax % | −28.14% | −12.64% | −21.36% | 84.09% | 34.82% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | — |
| Net Profit | −4.06 | 7.93 | −6.26 | 0.14 | 2.19 | −47.83 | −24.52 | −3.03 | −0.16 | −0.06 | −0.05 | −0.34 | −0.32 |
| EPS (₹) | −1.66 | 2.85 | −1.84 | 0.04 | 0.64 | −14.03 | −7.19 | −0.89 | −0.05 | −0.02 | −0.01 | −0.1 | −0.1 |
| Div. Payout % | 0% | 7.99% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | — |
Balance Sheet
₹ Cr| Particulars | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Equity Capital | 11.16 | 12.67 | 17.05 | 17.05 | 17.05 | 17.05 | 17.05 | 17.05 | 17.05 | 17.05 | 17.05 | 17.05 |
| Reserves | 36.01 | 50.22 | 50.17 | 50.19 | 52.4 | 4.57 | −19.1 | −22.13 | −22.28 | −22.35 | −22.4 | −22.74 |
| Borrowings | 40.29 | 72.05 | 65.77 | 73.38 | 74.93 | 75.88 | 1.75 | 1.75 | 1.76 | 1.78 | 1.79 | 2.17 |
| Other Liabilities | 26.6 | 30.66 | 37.27 | 31.21 | 25.32 | 39.37 | 34.99 | 12.28 | 8.72 | 8.77 | 8.73 | 8.67 |
| Total Liabilities | 114 | 166 | 170 | 172 | 170 | 137 | 34.69 | 8.95 | 5.25 | 5.25 | 5.17 | 5.15 |
| Fixed Assets | 22.95 | 32.89 | 38.64 | 72.31 | 82.44 | 81.19 | 0 | 0 | 0 | 0 | 0 | 0 |
| CWIP | 13.42 | 37.53 | 48.27 | 21.59 | 17.26 | 12.67 | 0.12 | 0 | 0 | 0 | 0 | 0 |
| Investments | 4.2 | 4.15 | 4.16 | 4.15 | 4.15 | 0.15 | 0.15 | 0.15 | 0.15 | 0.15 | 0.15 | 0.15 |
| Other Assets | 73.49 | 91.03 | 79.19 | 73.78 | 65.85 | 42.86 | 34.42 | 8.8 | 5.1 | 5.1 | 5.02 | 5 |
| Total Assets | 114 | 166 | 170 | 172 | 170 | 137 | 34.69 | 8.95 | 5.25 | 5.25 | 5.17 | 5.15 |
Cash Flow
₹ Cr| Particulars | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating | −16.49 | −9.61 | 19.66 | 6.69 | 12.36 | 9.07 | −14.25 | −0.15 | 0.02 | −0.01 | 0 | −0.39 |
| Investing | −5.1 | −34.42 | −18.59 | −10.7 | −9.74 | −2.69 | 93.77 | 0.12 | 0 | 0 | 0 | 0 |
| Financing | 31.53 | 35.54 | −1.91 | 4 | −2.66 | −7.57 | −80.25 | 0 | −0.03 | 0.02 | 0 | 0.39 |
| Net Cash Flow | 9.94 | −8.48 | −0.84 | −0.01 | −0.03 | −1.18 | −0.73 | −0.03 | −0.01 | 0.01 | 0 | −0.01 |
| Free Cash Flow | −37.12 | −45.37 | 0.96 | −4.13 | 2.5 | 6.24 | 79.49 | −0.03 | 0.02 | −0.01 | 0 | −0.39 |
| CFO/OP | −514 | −72 | −1,139 | 80 | 103 | −26 | 3,958 | 4 | −15 | 17 | 0 | 78 |
Ratios
| Particulars | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Debtor Days | 75.13 | 120 | 105 | 83.71 | 42.97 | 9.48 | Not meaningful for this period: the ratio divides by a base close to zero, so it is left blank rather than shown as a very large number. | 1,898 | — | — | — | — |
| Inventory Days | 134 | 181 | 113 | 111 | 124 | 89.78 | — | 364 | — | — | — | — |
| Days Payable | 186 | 190 | 177 | 133 | 75.89 | 35.11 | — | 879 | — | — | — | — |
| Cash Conversion Cycle | 23.09 | 111 | 40.6 | 61.73 | 91.1 | 64.15 | Not meaningful for this period: the ratio divides by a base close to zero, so it is left blank rather than shown as a very large number. | 1,383 | — | — | — | — |
| Working Capital Days | 60.53 | 117 | 20.61 | 28.43 | 1.99 | −161 | Not meaningful for this period: the ratio divides by a base close to zero, so it is left blank rather than shown as a very large number. | 0 | — | — | — | — |
| ROCE % | 2.89% | 9.65% | −2.85% | 4.06% | 8.78% | −33.35% | −0.56% | — | — | — | — | — |
Insights
BetaAI-extracted from concalls & annual reports · figures as reported, with sources
Log in to view Nutraplus insights
62 extracted metrics across FY10–FY27.
Documents
- Concall · Sep 2016PPT
- 12 Jun 2025
- 9 May 2024
- 21 Mar 2023
- 22 Mar 2022
- 25 May 2021
- General announcements 13 Oct 2026
Frequently Asked Questions about Nutraplus India
What does Nutraplus India Ltd do?
Where is Nutraplus India Ltd (NUTRA) listed?
Which sector does Nutraplus India Ltd belong to?
Company Information
Nutraplus India is engaged in the Business of Drugs and Pharmaceuticals.
For AI agents and developers
Reading this as an AI agent, LLM or automated pipeline? Every page on Tapetide is also published as clean Markdown — no navigation, no scripts, just the data. Fetch https://tapetide.com/stocks/524764.md for Nutraplus India Ltd: dated key facts, then this page's sections in order: latest price, key fundamentals, peer comparison, the Tapetide Score, technical indicators, analyst ratings, growth rates, analyst forecasts, the AI analysis and news digest (labelled as AI-generated), financial statements, shareholding pattern, documents and the FAQ.
Append .md to any Tapetide URL for
the same treatment. A full index of what we publish is at /llms.txt and /llms-full.txt. For
live, structured queries instead of documents, use our Indian stock market MCP server.